These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 12173013

  • 1. Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice: implications for pre-therapeutic prediction of treatment outcomes with (99m)Tc-sestamibi, (201)Tl chloride and (99m)Tc-HL91.
    Kinuya S, Yokoyama K, Li XF, Bai J, Watanabe N, Shuke N, Takayama T, Bunko H, Michigishi T, Tonami N.
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1006-11. PubMed ID: 12173013
    [Abstract] [Full Text] [Related]

  • 2. Anti-angiogenic therapy and chemotherapy affect 99mTc sestamibi and 99mTc-HL91 accumulation differently in tumour xenografts.
    Kinuya S, Yokoyama K, Fukuoka M, Mori H, Shiba K, Watanabe N, Shuke N, Michigishi T, Tonami N.
    Nucl Med Commun; 2005 Dec; 26(12):1067-73. PubMed ID: 16264352
    [Abstract] [Full Text] [Related]

  • 3. Accumulation of Tc-99m HL91 in tumor hypoxia: in vitro cell culture and in vivo tumor model.
    Lee BF, Chiu NT, Hsia CC, Shen LH.
    Kaohsiung J Med Sci; 2008 Sep; 24(9):461-72. PubMed ID: 19073378
    [Abstract] [Full Text] [Related]

  • 4. Technetium-99m-labelled HL91 and technetium-99m-labelled MIBI SPECT imaging for the detection of ischaemic viable myocardium: a preliminary study.
    Liu M, Ma Z, Guo X, Zhu J, Su J.
    Clin Physiol Funct Imaging; 2012 Jan; 32(1):25-32. PubMed ID: 22152075
    [Abstract] [Full Text] [Related]

  • 5. Scintigraphy for interpretation of malignant tumours of the head and neck: comparison of technetium-99m-hexakis-2-methoxyisobutylisonitrile (Tc-MIBI) and thallium-201-chloride (Tl-201).
    Sato T, Kawabata Y, Kobayashi Y, Suenaga S, Indo H, Kawano K, Iwashita Y, Morita Y, Majima HJ.
    Dentomaxillofac Radiol; 2005 Sep; 34(5):268-73. PubMed ID: 16120875
    [Abstract] [Full Text] [Related]

  • 6. Reduction of 99mTc-sestamibi and 99mTc-tetrofosmin uptake in MRP-expressing breast cancer cells under hypoxic conditions is independent of MRP function.
    Kinuya S, Li XF, Yokoyama K, Mori H, Shiba K, Watanabe N, Shuke N, Bunko H, Michigishi T, Tonami N.
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1529-31. PubMed ID: 14579093
    [Abstract] [Full Text] [Related]

  • 7. Preclinical evaluation of the novel hypoxic marker 99mTc-HL91 (Prognox) in murine and xenograft systems in vivo.
    Honess DJ, Hill SA, Collingridge DR, Edwards B, Brauers G, Powell NA, Chaplin DJ.
    Int J Radiat Oncol Biol Phys; 1998 Nov 01; 42(4):731-5. PubMed ID: 9845086
    [Abstract] [Full Text] [Related]

  • 8. The preparation and biological characterization of a new HL91-derivative for hypoxic imaging on stroke mice.
    Hsia CC, Huang FL, Lin CH, Shen LH, Wang HE.
    Appl Radiat Isot; 2010 Sep 01; 68(9):1610-5. PubMed ID: 20395152
    [Abstract] [Full Text] [Related]

  • 9. Hypoxia-induced redox alterations and their correlation with 99mTc-MIBI and 99mTc-HL-91 uptake in colon cancer cells.
    Abrantes AM, Serra ME, Gonçalves AC, Rio J, Oliveiros B, Laranjo M, Rocha-Gonsalves AM, Sarmento-Ribeiro AB, Botelho MF.
    Nucl Med Biol; 2010 Feb 01; 37(2):125-32. PubMed ID: 20152711
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo study of 99mTc-MIBI encapsulated in PEG-liposomes: a promising radiotracer for tumour imaging.
    Belhaj-Tayeb H, Briane D, Vergote J, Kothan S, Léger G, Bendada SE, Tofighi M, Tamgac F, Cao A, Moretti JL.
    Eur J Nucl Med Mol Imaging; 2003 Apr 01; 30(4):502-9. PubMed ID: 12536243
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo tracer characteristics of an established multidrug-resistant human colon cancer cell line.
    Lorke DE, Krüger M, Buchert R, Bohuslavizki KH, Clausen M, Schumacher U.
    J Nucl Med; 2001 Apr 01; 42(4):646-54. PubMed ID: 11337555
    [Abstract] [Full Text] [Related]

  • 15. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study.
    Kapur A, Latus KA, Davies G, Dhawan RT, Eastick S, Jarritt PH, Roussakis G, Young MC, Anagnostopoulos C, Bomanji J, Costa DC, Pennell DJ, Prvulovich EM, Ell PJ, Underwood SR.
    Eur J Nucl Med Mol Imaging; 2002 Dec 01; 29(12):1608-16. PubMed ID: 12458395
    [Abstract] [Full Text] [Related]

  • 16. In vivo imaging of human colon cancer xenografts in immunodeficient mice using a guanylyl cyclase C--specific ligand.
    Wolfe HR, Mendizabal M, Lleong E, Cuthbertson A, Desai V, Pullan S, Fujii DK, Morrison M, Pither R, Waldman SA.
    J Nucl Med; 2002 Mar 01; 43(3):392-9. PubMed ID: 11884500
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Technetium-99m HL91 uptake as a tumour hypoxia marker: relationship to tumour blood flow.
    Tatsumi M, Yutani K, Kusuoka H, Nishimura T.
    Eur J Nucl Med; 1999 Feb 01; 26(2):91-4. PubMed ID: 9933342
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.